Workplace injuries affect approximately 4.1 million Americans annually (1) . More than half of these injured individuals will have to miss work and receive long-term medical care. Worker’s compensation plans provide partial wages during the time of injury and recovery period in addition to covering the cost of medical care. The recent trend among physicians treating work related injuries has been the practice of prescribing high and sometimes dangerous doses of opioid pain medications for extended periods of time. Data from 2005-2008 in 17 states showed an average number of 1,599 cases requiring narcotics for non-surgical cases, with more than seven work days missed due to injury(2). Additionally, in an average of 6% of these cases, the narcotics were prescribed for long-term periods of time. These drugs may include but are not limited to hydrocodone, fentanyl, methadone, and oxycodone. Approximately 50-90% of injured workers will receive narcotics for chronic pain conditions (3). Opioid pain medications can have deadly side effects and the increased availability and dosages of these medications can be detrimental to an injured worker and prolong the time it takes to return to work.
Opioid pain medications are the most commonly prescribed medication in the United States(4). They work to decrease the perception of pain and increase pain threshold. While these drugs are helpful to decrease overall pain of various injuries and conditions, they are highly addictive and only address a portion of the pain process. Common side effects may be mild such as constipation and fatigue, however, they have also been linked to more severe side effects including sleep apnea, decreased hormone production, and increased falls and broken bones among the elderly population(4). Additionally patients taking opioid pain medications for long periods of time can become addicted and experience serious symptoms of withdrawal which include nausea, shaking, chills, and sweating when finishing a course of these medications (5). Lately there has also been in an increase in drug overdose leading to death. In a study that observed 10,000 patients who were prescribed opioids for 90 days, 51% experienced at least one overdose, and six individuals died as a result of overdose 6. In 2008 the number of deaths resulting from overdose reached nearly 15,000 individuals(1).
Increased availability and access to opioid pain medications is one of the main problems leading to addiction and overdose among injured workers. Some physicians are prescribing these medications to treat acute and long-term pain disorders such as arthritis and musculoskeletal pain. Oftentimes high doses are prescribed and the dosage continues to increase over time as tolerance to the effects of the medications increases. Instead of treating the underlying physiological conditions causing the painful condition, opioid pain medications are prescribed to help manage and mask the pain associated with a work related injury. They are prescribed for many reasons, however, a few of the most common are pressure from patients to prescribe a strong medication that will lead to decreased pain, as well as pressure from insurance companies to prescribe the most cost-effective generic pain medications. Patients may experience temporary pain relief while on these medications, however chronic pain may persist long after the injury has healed.
Prescribing high dose opioid pain medications for work related injuries often leads to other injuries and physiologic impairments. In many cases, patients remain out of work for much longer than individuals who are not prescribed opioids, as they often develop new health conditions and require more medications. In the study conducted by the Danish Health Interview Survey in 2000 observing 10,434 individuals, patients who were not prescribed opioid pain medications to treat their injuries recovered four times more often than individuals prescribed opioid pain medications(7). Additionally, in this study patients taking opioid pain medications were shown to have a lower quality of life and higher death risk than those patients managing pain without opioids.
Some patients who are prescribed opioid pain medications, especially long-term, may develop other serious conditions such as obesity, mood disorders, and depression. An injured worker who is taking medication for a pain condition may not be able to exercise regularly and weight gain is fairly common. Opioid pain medications can also have an effect on overall mood and quality of life. If an individual takes these medications long-term it can be very hard to stop taking them. The patient can experience large amounts of anxiety and depression when decreasing the dosage or attempting to discontinue the medication all together. Research has found that of the 1.9 million workers claims that were filed between 2007-2008, those who previously had or developed a co-morbidity as a result of injury such as depression, obesity, or hypertension, experienced more costly treatments and often longer treatment plans all together(8).
Work related injuries will continue to be an issue for insurers and employers. The overprescribing of opioid pain medications in this country must be addressed by physicians, insurance companies, and drug manufacturers. The conversion of acute pain to chronic pain associated with a work related injury can be managed in a more efficient way that will allow an injured worker to return to work as soon as they are healed without the burden of addiction or other opioid pain medication related side effects. Theramine can be used as a complimentary or standalone therapy among this vulnerable population and can provide treating physicians with the ability to prescribe the lowest effective dose of an opioid pain medication while addressing the underlying pathology of the pain process.
Theramine is a prescription only medication regulated by the FDA as a medical food. Medical foods are prescription only medications which address the underlying pathology of pain associated with the work related injury or illness. Theramine is clinically proven to correct amino acid deficiencies associated with chronic pain syndromes, and improve the overall perception of pain(9). Theramine is designed to manage the increased nutritional requirements associated with acute or chronic pain conditions. Theramine is a proprietary amino acid formulation that, by providing neurotransmitter precursors, helps stimulate production of neurotransmitters that are often deficient in pain conditions. The ingredients in Theramine are Generally Recognized as Safe by the FDA, and are specially formulated utilizing a proprietary Targeted Cellular Technology to facilitate the uptake and metabolizing of milligram quantities of amino acids and other nutrients. There have been no reported adverse side effects associated with the clinical application of over 50 million individual doses of Theramine. The most common side effects associated with amino acid therapies are headache, dry mouth, and upset stomach and are often short term, and can be decreased with increased fluid intake. Theramine can be administered in conjunction with the lowest effective doses of an opiate or NSAID pain medication without loss of efficacy(10). Treating work related injuries with Theramine may prove to be one possible medication solution to control pain and help decrease the quantity and dosages of opioid pain medications administered in the United States.
7) A Population-based Cohort Study on Chronic Pain:The Role of Opioids Per Sjøgren, MD, DMSC,* Morten Grønbæk, PhD, Vera Peuckmann, PhD, and Ola Ekh-+olm, PhDw, Lippincott Williams & Wilkins, 2010.
9) Shell WE, Silver D, Charuvastra E, Pavlik S, Bullias D; “Theramine and Ibuprofen for the treatment of chronic low back pain double blind clinical trial”, 2010 Targeted Medical Pharma Inc.
10) Shell WE et al.; “Theramine and Naproxen for the treatment of low back pain, a double bind clinical trial”; Americal Journal of Therapeutics April,2012.